According to the Complaint, Covetrus is a global, technology-enabled Animal Health Business that touts a comprehensive service and technology platform and supply chain infrastructure for the veterinary markets. Covetrus was formed when Henry Schein, a large publicly traded health care company, spun-off its Animal Health Business and combined it with VFC, a private technology company focused on veterinary markets.

According to the Complaint, Myriad is a molecular diagnostic company that develops and markets predictive, personalized, and prognostic medicine tests worldwide. Myriad offers, among other products, GeneSight, a DNA genotyping test to aid psychotropic drug selection for depressed patients; and Foresight, a prenatal test in the expanded carrier screening market for future parents to assess their risk of passing on a recessive genetic condition to their offspring.

According to the Complaint, Sundial purports to produce and market craft pioneering cannabis brands to "Heal, Help and Play." Sundial operates five facilities, including two facilities in Alberta, Canada and three in the United Kingdom, and as of August 2019, was building a third Canadian facility in British Columbia.

According to the Complaint, ProPetro is an oilfield services company that provides hydraulic fracturing and complementary services to leading upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources.

According to the Complaint, Venator is a global chemical company primarily focused on the development and manufacture of Titanium Dioxide. Titanium Dioxide is a naturally occurring, opaque mineral that is used to enhance whiteness, opacity, and brightness in thousands of manufactured items such as coatings, plastics, paper, paints, inks, fibers, food, and personal care products, and is the mainstay of Venator's range of products.

According to the Complaint, MINDBODY is a provider of cloud-based business management software for the wellness services industry, e.g., salons and spas, and a rapidly growing marketplace for wellness services. The Company offers integrated software and payment platforms to assist wellness business owners run, market, and build their businesses, while engaging consumers by aggregating available classes and appointments, and enabling rapid discovery, booking and payment. The Company conducted its initial public offering in June 2015.

According to the Complaint, AmTrust is an insurance holding company headquartered in New York, New York and incorporated in Delaware. Through its subsidiaries, AmTrust provides specialty property and casualty insurance products. AmTrust provides insurance services in all fifty states, the District of Columbia, and Puerto Rico.

According to the Complaint, Textron is a global manufacturer of small aircrafts and recreational vehicles. On March 6, 2017, Textron expanded its recreational vehicle business through its $316 million acquisition of Arctic Cat Inc. Upon the completion of this transaction, Arctic Cat became an indirect wholly-owned subsidiary of Textron. Arctic Cat designs and manufactures a variety of recreational vehicles, including all-terrain vehicles and snowmobiles. Arctic Cat revenues are generated through sales to independent dealers.

According to the Complaint, SAExploration provides seismic data acquisition, logistical support, and processing and integrated reservoir geosciences services in North America, South America, the Asia Pacific, and West Africa.

According to the Complaint, NetApp provides a range of hybrid cloud data services that simplify management of applications and data across cloud and on-premises environments to accelerate digital transformation.

According to the Complaint, Granite purports to be one of the largest diversified infrastructure companies in the United States. In the public sector, the Company primarily focuses on heavy-civil infrastructure projects such as roads, highways, and power-related facilities. In the private sector, the Company provides site preparation and infrastructure services for residential development, energy development, and other facilities.

According to the Complaint, Pluralsight utilizes a subscription-based business model known as "software as a service" ("SaaS"), whereby the Company's software is licensed to users on a subscription basis. Pluralsight generates substantially all of its revenue based on these subscriptions. To drive revenue growth, Pluralsight relies on its large direct sales force which sells subscriptions to business and enterprise users. Pluralsight utilizes a metric known as "billings" as a primary measure of growth, which it defines as total revenue for a period, plus the change in deferred revenue based on the subscription period.

According to the Complaint, through its "end-to-end, built-for-purpose, technology enabled platform," Evolent aligns or partners up with health systems and physicians organizations and provides "integrated, technology-enabled services" and third-party administration ("TPA") to partners "to transition their organization and business model to succeed in value-based payment models."

According to the Complaint, 2U is an education technology company that works with universities to provide
online graduate programs and certificates for working adults.

According to the Complaint, Cardinal Health, Inc. is a global, integrated healthcare services and products company.

According to the Complaint, Carbonite is a software company that provides cloud-based backup services, including the Server Backup VM Edition for managed services providers ("MSPs"), which was designed to allow MSPs to protect their virtual data both locally and in their own cloud.

According to the Complaint, GTT Communications, Inc. owns and operates a global Tier 1 internet network and provides cloud networking services to multinational clients.

According to the Complaint, Aclaris is a biopharmaceutical company that identifies, develops, and commercializes therapies to address unmet needs in medical and aesthetic dermatology and immunology. Its lead product ESKATA is a hydrogen peroxide topical solution that is FDAapproved to treat raised seborrheic keratosis, a common non-malignant tumor.

According to the Complaint, Oasmia purports to be a pharmaceutical company focused on innovative treatments within human and animal oncology.

According to the Plaintiff's law firm press release, Mallinckrodt, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza. The Company markets its branded products to physicians, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies.